Gilead Sciences Q3 Adj. EPS $2.55 Beats $2.19 Estimate, Sales $8.300B Beat $7.809B Estimate
Benzinga Newsdesk 3 days ago
NewsEarningsHotEarnings Beats
Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.19 by 16.44 percent. This is a 3.24 percent increase over earnings of $2.47 per share from the
Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.19 by 16.44 percent. This is a 3.24 percent increase over earnings of $2.47 per share from the same period last year. The company reported quarterly sales of $8.300 billion which beat the analyst consensus estimate of $7.809 billion by 6.28 percent. This is a 6.83 percent increase over sales of $7.769 billion the same period last year.